Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Swagat Sharma"'
Publikováno v:
Current Opinion in Nephrology & Hypertension.
Autor:
Swagat Sharma, Juan L. Pablo, Kirsten T. Tolentino, Wacey Gallegos, Jennifer Hinman, Madison Beninato, MacKenzie Asche, Anna Greka, Corey R. Hopkins
Publikováno v:
ChemMedChem. 17
The transient receptor potential cation channel 5 (TRPC5) plays an important role in numerous cellular processes. Due to this, it has gained considerable attention over the past few years as a potential therapeutic target. Recently, TRPC5 has been sh
Autor:
Swagat Sharma, Qi Peng, Anish K. Vadukoot, Christopher D. Aretz, Aaron A. Jensen, Alexander I. Wallick, Xinzhong Dong, Corey R. Hopkins
Publikováno v:
ACS Med Chem Lett
[Image: see text] The present study describes our continued efforts in the discovery and characterization of a series of 2-sulfonamidebenzamides as allosteric modulators of MrgX1. MrgX1 has been shown to be an attractive target as a nonopioid recepto
Autor:
Cortney E. Heim, Nagsen Gautam, Amy Aldrich, Sushil Kumar, Swagat Sharma, Anish K. Vadukoot, Yazen Alnouti, Christopher D. Aretz, Corey R. Hopkins, Tammy Kielian
Publikováno v:
ACS Med Chem Lett
[Image: see text] Herein we report the synthesis, SAR, and biological evaluation of a series of 1H-pyrrolo[2,3-b]pyridine-2-carboxamide derivatives as selective and potent PDE4B inhibitors. Compound 11h is a PDE4B preferring inhibitor and exhibited a
Autor:
Corey R. Hopkins, Xinzhong Dong, Swagat Sharma, Qi Peng, Alexander Wallick, Christopher D Aretz, Anish K. Vadukoot, Aaron Jensen
The present study describes our continued efforts in the discovery and characterization of a series of 2-sulfonamidebenzamides as allosteric modulators of MrgX1. MrgX1 has been shown to be an attractive target as a non-opioid receptor for the potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7660425de7c53565282262c8d207f26e
https://doi.org/10.33774/chemrxiv-2021-7cq5k
https://doi.org/10.33774/chemrxiv-2021-7cq5k
Autor:
Christopher D. Aretz, Yazen Alnouti, Lauren Lesiak, C. David Weaver, Yashpal S. Chhonker, Nikilesh V. Dhuria, Sushil Kumar, Yu Du, Nagsen Gautam, Swagat Sharma, Corey R. Hopkins
Publikováno v:
RSC Med Chem
The present study describes the discovery and characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as G protein-gated inwardly-rectifying potassium (GIRK) channel activators. From our pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2820c33e200f746c3cd7ae11f0a6780c
https://europepmc.org/articles/PMC8372201/
https://europepmc.org/articles/PMC8372201/
Autor:
Corey R. Hopkins, Swagat Sharma
Publikováno v:
Journal of Medicinal Chemistry. 62:7589-7602
Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in nume
Autor:
Yazen Alnouti, Corey R. Hopkins, Kristopher K. Abney, Nagsen Gautam, Krystian A. Kozek, Sushil Kumar, Swagat Sharma, C. David Weaver
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:791-796
The present study describes the discovery and characterization of a series of 5-aryl-2H-tetrazol-3-ylacetamides as G protein-gated inwardly-rectifying potassium (GIRK) channels activators. Working from an initial hit discovered during a high-throughp
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:155-159
The transient receptor potential cation channel 5 (TRPC5) has been previously shown to affect podocyte survival in the kidney. As such, inhibitors of TRPC5 are interesting candidates for the treatment of chronic kidney disease (CKD). Herein, we repor
Autor:
Punita Dhawan, Sandeep Rana, Balawant Kumar, Swagat Sharma, Amarnath Natarajan, Saiprasad Gowrikumar, Corey R. Hopkins, David Oupicky, Mark Primeaux, Amar B. Singh, Rizwan Ahmad
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2168, p 2168 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2168, p 2168 (2021)
Background: Despite recent advances in therapies, resistance to chemotherapy remains a critical problem in the clinical management of colorectal cancer (CRC). Cancer stem cells (CSCs) play a central role in therapy resistance. Thus, elimination of CS